VIRIDIAN THERAPEUTICS INC
VRDNNASDAQ🏆 #1566 by market capUS Equity
$23.00▼ $0.06 (−0.26%)
Market closed · at close1h—
24h▼ 0.3%
7d▲ 9.3%
14d▲ 15.6%
30d▲ 21.2%
1y▲ 28.0%
🏦Market Cap
$2.54B
Small Cap
📈Revenue Growth (YoY)
+23220.3%
High Growth
📊Gross Margin
2.4%
Thin
💵FCF Margin
—
⚖️P/S Ratio
35.1x
Expensive
Otter Score
55
Weak
Trading Snapshot
- Day Range
- $22.65 – $23.22
- 52-Week Range
- $13.18 – $34.29
- Volume
- $2.73B
- Avg Volume
- $2.39B
- Shares Outstanding
- 110.4M
- Next Earnings
- Sep 1, 2026
Fundamentals Snapshot
- Annual Revenue
- $60M
- Last Q Revenue
- $14M
- P/E Ratio
- —
- P/S Ratio
- 35.1x
- EPS (TTM)
- $-3.90
- Dividend Yield
- —
Why Investors Own VRDN
- ✓High-growth profile — revenue up -0.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 39% gross margin and 9% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$60M▼ −3.9% YoY
Gross Margin (TTM)
38.8%▲ +0.8% YoY
Operating Income (TTM)
$7M▼ −3.9% YoY
Free Cash Flow (TTM)
$5M▼ −3.9% YoY
About VIRIDIAN THERAPEUTICS INC
A company profile for VIRIDIAN THERAPEUTICS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
55/100
Analyst Price Target
ⓘAverage Target
$22.20
▼ −3.5% Downside
High Target$24.68
Low Target$16.72
Based on 24 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
VIRIDIAN THERAPEUTICS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift VRDN price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
VIRIDIAN THERAPEUTICS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.